1,721,060 research outputs found
Blood: the last 20 years of discovery.
No full textThroughout the last few years, significant attention is being paid to progenitor cells, whose isolation has enhanced the understanding of biology of tissue formation and regeneration. Hematopoietic stem cells are historically the most well studied, they have been shown to provide the best chance for patients who undergo bone marrow transplantation, peripheral blood cell transplantation and cord blood transplantation. To date, the therapeutical potential of stem cells has become increasingly evident in many diseases, leading, beyond the classical procedures, to the implementation of non-haematological trials
Red blood cell storage lesion and adverse clinical outcomes: post hoc ergo propter hoc?
No full text[No abstract available
L’impatto della pandemia da virus A/H1N1 sulla organizzazione del sistema sangue in Italia.
No full textHydroxyethyl-starch use and PBM. a necessary update to the italian national guidelines
Full text linkHydroxyethyl-starch use and PBM a necessary update to the italian national guideline
Alternative Blood Products and Clinical Needs in Transfusion Medicine
Full text linkThe primary focus of national blood programs is the provision of a safe and adequate blood supply. This goal is dependent on regular voluntary donations and a regulatory infrastructure that establishes and enforces standards for blood safety. Progress in ex vivo expansion of blood cells from cell sources including peripheral blood, cord blood, induced pluripotent stem cells, and human embryonic stem cell lines will likely make alternative transfusion products available for clinical use in the near future. Initially, alloimmunized patients and individuals with rare blood types are most likely to benefit from alternative products. However, in developed nations voluntary blood donations are projected to be inadequate in the future as blood usage by individuals 60 years and older increases. In developing nations economic and political challenges may impede progress in attaining self-sufficiency. Under these circumstances, ex vivo generated red cells may be needed to supplement the general blood supply
Studio multicentrico sulle varianti dell'antigene D nella popolazione italiana:dati preliminari del progetto Arcobaleno
No full text- …
